Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
Fiche publication
Date publication
mai 2016
Journal
European journal of cancer (Oxford, England : 1990)
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FRAISSE Jean
Tous les auteurs :
Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C, Charytansky H, Rouzier R, Daraï E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Fraisse J, Dravet F, Chauvet MP, Goncalves A, Lambaudie E
Lien Pubmed
Résumé
The rate of axillary recurrence (AR) after sentinel lymph node biopsy is usually low but few studies investigated its impact on survival. Our aim was to determine the rate and predictive factors of AR in a large cohort of breast cancer patients and its impact on survival.
Mots clés
Adult, Aged, Axilla, Biomarkers, Tumor, analysis, Breast Neoplasms, chemistry, Chemotherapy, Adjuvant, Female, France, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Lymph Nodes, chemistry, Lymphatic Metastasis, Mastectomy, adverse effects, Middle Aged, Multivariate Analysis, Neoplasm Micrometastasis, Odds Ratio, Predictive Value of Tests, Proportional Hazards Models, Radiotherapy, Adjuvant, Retrospective Studies, Risk Factors, Sentinel Lymph Node Biopsy, Time Factors, Treatment Outcome, Triple Negative Breast Neoplasms, chemistry
Référence
Eur. J. Cancer. 2016 May;58:73-82